BROWN BROTHERS HARRIMAN & CO - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
BROWN BROTHERS HARRIMAN & CO ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$6,243,203
-1.2%
61,292
-2.1%
0.06%
+7.8%
Q2 2023$6,320,801
+7.8%
62,638
-1.7%
0.05%
+4.1%
Q1 2023$5,863,896
-9.0%
63,738
-10.2%
0.05%
-12.5%
Q4 2022$6,442,481
+15.2%
71,015
-3.5%
0.06%
+7.7%
Q3 2022$5,594,000
-20.9%
73,593
-12.1%
0.05%
-14.8%
Q2 2022$7,075,000
-16.7%
83,695
-13.5%
0.06%
+1.7%
Q1 2022$8,493,000
-21.7%
96,789
-21.9%
0.06%
-1.6%
Q4 2021$10,845,000
-6.6%
123,990
-12.7%
0.06%
-11.6%
Q3 2021$11,613,000
-16.6%
142,004
-6.9%
0.07%
-15.9%
Q2 2021$13,918,000
-17.7%
152,548
-22.9%
0.08%
-24.1%
Q1 2021$16,916,000
-36.1%
197,894
-29.4%
0.11%
-38.6%
Q4 2020$26,458,000
-10.9%
280,189
-17.9%
0.18%
-17.4%
Q3 2020$29,688,000
-91.4%
341,397
-91.4%
0.21%
-91.8%
Q2 2020$345,423,000
+2.4%
3,954,923
-3.3%
2.60%
-5.6%
Q1 2020$337,383,000
-18.8%
4,091,972
-6.7%
2.75%
+3.7%
Q4 2019$415,441,000
+0.8%
4,387,385
-7.5%
2.66%
-3.6%
Q3 2019$412,106,000
-24.1%
4,742,297
-20.3%
2.75%
-23.7%
Q2 2019$543,160,000
-8.1%
5,948,523
-3.2%
3.61%
-11.4%
Q1 2019$590,901,000
+6.2%
6,146,252
-5.2%
4.07%
-3.2%
Q4 2018$556,191,000
-14.1%
6,481,658
-13.8%
4.21%
+4.8%
Q3 2018$647,623,000
+6.5%
7,516,511
-6.7%
4.01%
+7.5%
Q2 2018$608,360,000
-15.7%
8,053,479
-9.8%
3.73%
-10.4%
Q1 2018$721,549,000
-6.5%
8,924,544
-2.9%
4.16%
-1.8%
Q4 2017$771,729,000
-10.7%
9,191,630
-8.7%
4.24%
-7.9%
Q3 2017$864,581,000
+2.0%
10,070,828
-0.8%
4.61%
+0.3%
Q2 2017$847,266,000
+5.7%
10,150,549
-6.0%
4.59%
+5.6%
Q1 2017$801,870,000
+0.3%
10,796,684
-1.6%
4.35%
-0.3%
Q4 2016$799,147,000
+7.4%
10,971,272
+16.5%
4.37%
+10.6%
Q3 2016$743,917,000
-7.0%
9,421,436
-2.8%
3.95%
-4.9%
Q2 2016$799,529,000
+14.2%
9,690,090
+0.3%
4.15%
+14.9%
Q1 2016$700,051,000
-7.0%
9,663,868
+10.5%
3.62%
-8.9%
Q4 2015$752,720,000
-11.9%
8,748,494
-5.8%
3.97%
-8.7%
Q3 2015$854,074,000
-10.7%
9,291,495
-4.5%
4.35%
-2.9%
Q2 2015$956,344,000
-3.8%
9,724,869
-3.6%
4.47%
-0.5%
Q1 2015$994,467,000
+3.4%
10,084,854
-2.9%
4.50%
+11.0%
Q4 2014$961,942,000
-9.8%
10,381,419
-8.4%
4.05%
-5.6%
Q3 2014$1,066,622,000
+3.4%
11,331,374
-0.6%
4.29%
+2.7%
Q2 2014$1,031,534,000
-2.0%
11,394,385
-8.0%
4.18%
-7.0%
Q1 2014$1,053,101,000
+6.2%
12,386,504
+0.4%
4.50%
+0.4%
Q4 2013$991,629,000
-2.1%
12,336,767
-6.6%
4.48%
-6.6%
Q3 2013$1,013,014,000
+10.1%
13,205,757
+1.5%
4.79%
+10.0%
Q2 2013$920,292,000
+3.1%
13,015,019
+3.9%
4.36%
-5.4%
Q1 2013$892,416,00012,526,8984.61%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders